Skip to main content

Featured

Italy Advances Tougher Measures on Migrant Arrivals

ILE PHOTO: Italian Prime Minister Giorgia Meloni attends a bilateral meeting with U.S. Vice President JD Vance (not pictured), during his visit to the Milano Cortina 2026 Winter Olympics in Milan, Italy, February 6, 2026.  Italy’s government has approved a new migration bill that would grant authorities the power to impose temporary naval blockades during periods of intense pressure on the country’s borders. The proposal, backed by Prime Minister Giorgia Meloni, is designed to curb irregular sea crossings by restricting access to Italian territorial waters. The draft law would allow officials to bar vessels from entering for up to 30 days, with the option to extend the measure to six months if national security or public order is deemed at risk. The plan also strengthens border surveillance, increases penalties for human smuggling, and expands the list of offenses that can lead to deportation. Supporters argue the move is necessary to manage migration flows more effectively, whi...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment